Health, Wellbeing, and Prognosis of Australian Adolescents with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Case-Controlled Follow-Up Study. — CFSMEATLAS
Health, Wellbeing, and Prognosis of Australian Adolescents with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Case-Controlled Follow-Up Study.
Josev, Elisha K, Cole, Rebecca C, Scheinberg, Adam et al. · Journal of clinical medicine · 2021 · DOI
Quick Summary
This study followed Australian teenagers with ME/CFS for about two years after diagnosis to see how they were doing. While many young people improved in mood and some symptoms, fatigue, pain, and overall quality of life stayed significantly worse compared to healthy teenagers. About two-thirds of the teens still had ME/CFS at follow-up, suggesting the condition often persists in the early years after diagnosis.
Why It Matters
This study provides evidence that ME/CFS in adolescents often persists beyond the initial years following diagnosis, challenging potential misconceptions about adolescent prognosis. Understanding that fatigue, pain, and reduced quality of life are particularly persistent symptoms informs realistic clinical counseling and highlights the need for early intervention strategies in this population.
Observed Findings
65% of adolescents who met ME/CFS diagnostic criteria at baseline continued to fulfill criteria at follow-up (mean 2 years).
Pain was the most frequently experienced symptom throughout the study period and was significantly associated with diagnostic criteria persistence (R=0.6, p=0.02).
ME/CFS patients showed significant improvement in psychological wellbeing and several health domains over time, yet remained significantly worse than controls in fatigue, pain, and health-related quality of life.
82% of patients at follow-up self-reported still having ME/CFS, with 79% of these meeting formal diagnostic criteria.
Healthy controls remained relatively stable across all measured domains, while ME/CFS patients showed more dynamic changes.
Inferred Conclusions
ME/CFS in adolescents typically persists into the early years following diagnosis, with a majority continuing to fulfill diagnostic criteria at 1-5 year follow-up.
Fatigue, pain, and reduced quality of life are the most clinically persistent domains and may represent key targets for intervention.
Clinicians should provide realistic prognosis expectations to newly diagnosed adolescents and families, emphasizing early intervention needs rather than expecting natural remission.
Remaining Questions
What factors determine which adolescents achieve sustained remission versus persistent ME/CFS, given that baseline predictors were largely non-significant?
What This Study Does Not Prove
This study does not establish what causes ME/CFS or why some adolescents continue to meet criteria while others may recover more fully. The association between baseline pain and later criteria fulfillment is correlational, not causal, and results cannot be generalized beyond this Australian cohort or to adolescents diagnosed elsewhere. The study design cannot determine which interventions might improve prognosis.